NN3201, a Novel C-Kit Targeting ADC, Exhibits Robust Preclinical AntiTumor Efficacy in SCLC & GIST Models
Time: 11:30 am
day: Day Two
Details:
- Navigating the effects of NN3201 in small cell lung cancer
- Exploring a novel C-Kit targeting ADC
- Showing anti-tumor efficacy in SCLC and GIST models
